Riken Disputes STAP Researcher's Latest Claim For Controversial Work
This article was originally published in PharmAsia News
Executive Summary
Japan's Riken institute launched the latest salvo in a dispute with one of its researchers, rejecting her claim that a third party had replicated her controversial stem cell discovery.